Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gap junction-mediated intercellular communication in ischemic preconditioning.

David Garcia-Dorado1, Marisol Ruiz-Meana, Ferran Padilla

  • 1Servicio de Cardiología, Hospital Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. dgdorado@hg.vhebron.es

Cardiovascular Research
|August 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycative Stress Disrupts the Mitochondrial-Lysosome Axis and Promotes Geroconversion in Aging Cardiomyocytes.

Aging cell·2026
Same author

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles.

Particle and fibre toxicology·2025
Same author

Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1.

Pharmacological research·2025
Same author

Involvement of connexin 43 in myocardial ischemia-reperfusion injury.

Cell and tissue research·2025
Same author

Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.

Biomarker research·2025
Same author

Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Ischemic preconditioning may protect heart cells by altering gap junction communication. This protective effect, particularly during reperfusion, warrants further investigation into gap junctions as key effectors.

Area of Science:

  • Cardiovascular Physiology
  • Cellular Signaling
  • Molecular Cardiology

Background:

  • Gap junction communication influences cell death in various tissues, including the myocardium.
  • During ischemia and reperfusion, altered gap junction function contributes to arrhythmias and cell death progression.
  • Ischemic preconditioning activates intracellular signaling pathways that modulate gap junction communication.

Purpose of the Study:

  • To review evidence supporting the hypothesis that gap junctions are end-effectors of ischemic preconditioning.
  • To explore the mechanisms by which ischemic preconditioning influences gap junction communication.
  • To assess the role of gap junctions in the protective effects of preconditioning against ischemia-reperfusion injury.

Main Methods:

Related Experiment Videos

  • Review of existing literature on gap junction communication and ischemic preconditioning.
  • Analysis of signaling pathways (e.g., PKC, MAPK) involved in modulating gap junctions.
  • Examination of connexin phosphorylation and its impact on intercellular communication.

    • Main Results:

    • Ischemic preconditioning influences gap junction communication via kinase activation and cGMP preservation.
    • Connexin phosphorylation by kinases (PKC, p38/MAPK, PKG) generally reduces intercellular communication.
    • Modifications in gap junction communication during reperfusion may reduce hypercontracture and cell death in preconditioned hearts.

    Conclusions:

    • Gap junctions are potential end-effectors of ischemic preconditioning, contributing to cardioprotection.
    • While effects during prolonged ischemia are limited, modulation of gap junctions during reperfusion is crucial.
    • Further research is needed to fully elucidate the role of gap junctions in ischemia-reperfusion injury protection.